Actinium Pharmaceuticals ATNM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.60 | -0.16 | -5,692 | -5 | ||
| 2025Q2 | 1.40 | -0.22 | -7,503 | -7 | ||
| 2025Q1 | 1.61 | 104.39 | -0.51 | -16,638 | -16 | |
| 2024Q4 | 1.26 | 112.82 | -0.21 | -7,505 | -7 | |
| 2024Q3 | 1.88 | 108.93 | -0.37 | -12,601 | -12 | |
| 2024Q2 | 7.40 | 109.38 | -0.38 | -12,418 | -11 | |
| 2024Q1 | 7.83 | 110.69 | -0.31 | -9,597 | -9 | |
| 2023Q4 | 5.08 | 110.93 | -0.33 | -10,343 | -9 | |
| 2023Q3 | 5.92 | 108.10 | -0.49 | -14,351 | -13 | |
| 2023Q2 | 7.42 | 103.04 | -0.58 | -15,642 | -15 | |
| 2023Q1 | 9.45 | 104.96 | -0.43 | -11,584 | -11 | |
| 2022Q4 | 10.65 | 106.05 | -0.43 | -11,291 | -11 | |
| 2022Q3 | 7.38 | 103.43 | -0.38 | -9,799 | -9 | |
| 2022Q2 | 4.81 | 101.07 | -0.33 | -7,850 | -8 | |
| 2022Q1 | 5.11 | 100.68 | -0.23 | -5,164 | -5 | |
| 2021Q4 | 6.01 | 100.47 | -0.36 | -8,048 | -8 | |
| 2021Q3 | 8.86 | 100.72 | -0.30 | -6,469 | -6 | |
| 2021Q2 | 7.91 | 101.08 | -0.25 | -5,075 | -5 | |
| 2021Q1 | 7.62 | 100.98 | -0.29 | -5,372 | -5 | |
| 2020Q4 | 7.80 | 100.86 | -0.37 | -6,435 | -6 |